Publications
- Ranibizumab for the treatment of choroidal neovascularization due to cause other than age related macular degeneration2019 | Faculty of Medicine in Hradec Králové
- Stereotactic radiotherapy for wet age-related macular degeneration (INTREPID): influence of baseline characteristics on clinical response2015 | Publication without faculty affiliation
- Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study2015 | Publication without faculty affiliation
- Effects of Treatment Change in Patients with Neovascular age-related Macular Degeneration; Results from the Czech National Registry2012 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form2011 | Faculty of Medicine in Hradec Králové
- Intravitreous Bevacizumab (Avastin) in neovascular age related macular degeneration (pilot study) +1Publication without faculty affiliation
- Retina2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Changes in vascular density in the macula after pars plana vitrectomy for idiopathic macular hole with macular peeling and one type of flap2023 | Faculty of Medicine in Hradec Králové
- Randomized Trial of Biosimilar XSB-001 versus Reference Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration2023 | Publication without faculty affiliation
- Lucentis In The Treatment Of Diabetic Macular Edema, Two-Year Results2022 | Faculty of Medicine in Hradec Králové
Loading network view...